[Clinical and bacteriological features of intestinal dysbacteriosis in patients with pulmonary tuberculosis].
In patients with pulmonary tuberculosis, intestinal dysbacteriosis has clinical and bacteriological features characterized by the short-age of bifidobacteria (in 88-92%), by changes in the composition of Escherichia coli strains (in 38-42%), by the presence of Candida (in 58-62%), Proteus in half the patients, and by associated dysbacteriosis. Most (75%) patients show Stage III-IV intestinal dysbiosis formed after 3-4 months of continuous chemotherapy. There is a direct relationship between the magnitude of dysbiotic disorders and the duration of chemotherapy.
Lineva
Z E
ZE
NPO "Phthisiology", Iakutia.
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000382:microbiology*; D006801:Humans; D007410:Intestinal Diseases / Q000382:microbiology*; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
D000995:Antitubercular Agents
Kliniko-bakteriologicheskie osobennosti disbakterioza kishechnika u bol'nykh tuberkulezom legkikh.